Holen Sie sich die Stockscreener-App
491.53
2.39%
11.48
Handel nachbörslich:
491.53
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$480.05
Offen:
$487.75
24-Stunden-Volumen:
2.27M
Relative Volume:
1.00
Marktkapitalisierung:
$182.60B
Einnahmen:
$44.56B
Nettoeinkommen (Verlust:
$6.72B
KGV:
27.71
EPS:
17.7387
Netto-Cashflow:
$6.29B
1W Leistung:
+0.25%
1M Leistung:
-5.68%
6M Leistung:
+1.34%
1J Leistung:
-1.22%
1-Tages-Spanne:
$479.65
$494.36
1-Wochen-Bereich:
$471.83
$499.95
52-Wochen-Spanne:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
491.53 | 178.33B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
189.60 | 130.14B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
561.89 | 44.25B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
113.98 | 31.65B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
297.80 | 28.78B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | DZ Bank | Buy |
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Thermo Fisher Scientific Stock: Leading Life Sciences Provider Faces Mixed Institutional Flows Amid - AD HOC NEWS
Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM - joplinglobe.com
Northstar Advisory Group LLC Acquires Shares of 5,609 Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Position Trimmed by James Hambro & Partners LLP - MarketBeat
J. Safra Sarasin Holding AG Lowers Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Mn Services Vermogensbeheer B.V. Has $84.72 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
How is Thermo Fisher (TMO) Preparing to Deal With Rising Helium Prices - Insider Monkey
Thermo Fisher Scientific Inc. stock rises Monday, outperforms market - MarketWatch
Thermo Fisher Scientific (TMO) Sets Stage for Q4 Rally with Impressive Q3 Earnings and New 52-Week High - finance.yahoo.com
U.S. Automated Analyzer Market Is Going to Boom| Thermo Fisher - openPR.com
Thermo Fisher (TMO) Shares Up Since Jim Cramer Called the Firm “Unbelievable” - Insider Monkey
Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level Outlook - GlobeNewswire Inc.
Food Testing Kits Market Is Going to Boom | Thermo Fisher Scientific • Eurofins Scientific • SGS SA - openpr.com
Wedge Capital Management L L P NC Sells 6,634 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Canoe Financial LP Decreases Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Assenagon Asset Management S.A. Has $6.22 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Generate Investment Management Ltd Has $20.66 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Shares Sold by DAVENPORT & Co LLC - National Today
Eagle Rock Investment Company LLC Boosts Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by DAVENPORT & Co LLC - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Thermo Fisher Scientific Inc Stock (TMO) Moved Down by 3.31% on Mar 27: What Investors Need To Know - TradingKey
Vanguard Amends 13G: Reports 0 Shares in Thermo Fisher (TMO) - Stock Titan
Thermo Fisher Scientific collaborates with SHL Medical and expands Ridgefield site - ROI-NJ
Thermo Fisher Scientific (NYSE:TMO) Earns Buy Rating from Analysts at DZ Bank - MarketBeat
What You Need to Know Ahead of Thermo Fisher Scientific's Earnings Release - finance.yahoo.com
Thermo Fisher and SHL Medical collaborate to deliver fully integrated drug-device solutions - BioSpectrum Asia
Is Thermo Fisher Scientific (TMO) one of the best conservative stocks to buy right now? - MSN
Is Thermo Fisher Scientific (TMO) One of the Best Conservative Stocks to Buy Right Now? - finance.yahoo.com
U.S. Sterility Testing Market Set to Boom Rapidly by 2033 | Thermo - openPR.com
Czech National Bank Purchases 3,163 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
CCM Investment Advisers LLC Sells 2,163 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Sci. stock faces pressure amid life sciences slowdown and acquisition scrutiny as of M - AD HOC NEWS
Thermo Fisher, SHL Medical collab on drug delivery device production - Drug Delivery Business
Thermo Fisher and SHL Medical partner on integrated drug device solutions - PharmiWeb.com
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutio - PharmiWeb.com
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions - BioSpace
Thermo Fisher completes $8.9B buyout of Clario - medtechdive.com
Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Registry - Contract Pharma
Thermo Fisher Scientific and SHL Medical collaborate to deliver fully integrated Drug-Device Solutions - marketscreener.com
Thermo Fisher Scientific acquires Clario for nearly $8.9bn - Clinical Trials Arena
Thermo Fisher Scientific completes Clario Holdings acquisition - Medical Buyer
Thermo Fisher Scientific Inc. $TMO Stake Decreased by Professional Advisory Services Inc. - MarketBeat
U.S. Compound Management Market Is Going to Boom | Thermo Fisher - openPR.com
Thermo Fisher Scientific: Early Clario Close Enhances 2026 Growth Outlook and AI-Driven Competitive Position, Supporting Buy Rating - TipRanks
List of 55 Acquisitions by Thermo Fisher Scientific (Mar 2026) - Tracxn
Daymark Wealth Partners LLC Buys 7,003 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
PE investor group completes sale of clinical trial data firm Clario to Thermo Fisher for $8.9bn - pehub.com
Thermo Fisher Completes Strategic Acquisition of Clario Holdings - TipRanks
Thermo Fisher Scientific Inc. (TMO) announces the opening of cryo-electron microscopy drug discovery center in South San Francisco - MSN
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MarketWatch
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):